Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To determine the objective response rate at Day 50 in patients with relapsed or refractory classic systemic anaplastic large cell lymphoma (csALCL) or primary cutaneous anaplastic large cell lymphoma (pcALCL) treated with MDX-060.
Critère d'inclusion
- Relapsed or Refractory Classic Systemic or Primary Cutaneous Anaplastic Large Cell Lymphoma (ALCL)